Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRIW) Current Assets (2020 - 2025)

Biofrontera has reported Current Assets over the past 6 years, most recently at $18.1 million for Q4 2025.

  • Quarterly results put Current Assets at $18.1 million for Q4 2025, down 12.64% from a year ago — trailing twelve months through Dec 2025 was $18.1 million (down 12.64% YoY), and the annual figure for FY2025 was $18.1 million, down 12.64%.
  • Current Assets for Q4 2025 was $18.1 million at Biofrontera, up from $14.4 million in the prior quarter.
  • Over the last five years, Current Assets for BFRIW hit a ceiling of $48.5 million in Q3 2022 and a floor of $10.1 million in Q3 2021.
  • Median Current Assets over the past 5 years was $20.7 million (2024), compared with a mean of $27.6 million.
  • Biggest five-year swings in Current Assets: skyrocketed 378.38% in 2022 and later tumbled 46.51% in 2023.
  • Biofrontera's Current Assets stood at $46.4 million in 2021, then decreased by 7.07% to $43.1 million in 2022, then tumbled by 46.51% to $23.1 million in 2023, then decreased by 10.29% to $20.7 million in 2024, then decreased by 12.64% to $18.1 million in 2025.
  • The last three reported values for Current Assets were $18.1 million (Q4 2025), $14.4 million (Q3 2025), and $18.8 million (Q2 2025) per Business Quant data.